The WTO is not dead


10 December 2015

The last time the World Trade Organisation met was December 2013. The negotiations on the Transatlantic Trade and Investment Partnership (TTIP) and the campaign to stop TTIP had not even started. Trade seemed to be off the agenda and after years of stalled negotiations the WTO was expected to slowly become irrelevant.

The WTO is meeting again next week but this time in Nairobi and for the first time in Africa, and I will be there.

While there are some obvious similarities to previous WTO negotiations — fears that no agreement will be reached and entrenched positions of the global north and south — many other aspects are entirely different.

In the last two years, we have witnessed the rise of mega regional trade deals. TTIP is one such example between the US and the EU. But there are a plethora of other deals under negotiation. The Comprehensive Economic Trade Agreement (CETA) between Canada and the EU has been finalised and the text is waiting to be agreed by the European Parliament and national parliaments some time in 2016. The Trans Pacific Partnership (TPP) between the US and many Pacific rim countries was agreed in October 2015. The Trade In Services Agreement (TiSA) is in its 15th round of negotiations between over 50 countries.

These deals have many similarities. They are designed to open up new markets for global corporations and create the conditions for them to be as lucrative as possible. Perceived barriers to trade, such as labour standards, food safety regulations and publicly provided services, are to be reduced or removed. Additional legal protection to safeguard corporate profits from the effect of government policy - such as raising the minimum wage or introducing plain packaging on tobacco products - will be introduced. And of course, the negotiations are held in secret and away from parliamentary scrutiny.

The rise of mega regional trade deals is a direct response by neoliberal governments frustrated with the impasse in negotiations at the WTO. Unable to secure agreement of the 162 countries which make up the WTO, countries including the UK, EU and US decided to set their own agenda and begin negotiating the sort of neoliberal trade deals they wanted with other willing countries. Those countries which did not share this agenda could simply be left out of the negotiations, often countries from the global south.

Deals such as TTIP would include such a large proportion of world trade, that many have predicted mega regional deals to herald the end of the WTO. After all, if most global trade could be managed through regional trade deals, what role is left for the WTO?

What is interesting about next week's WTO ministerial meeting is that the rise of the mega regional trade deal could breathe new life into the WTO if these deals are brought into the WTO fold. This would be a tremendous result for the neoliberal governments, the UK included, which took these unpopular negotiations outside of the WTO to begin with. It is possible this might come to pass if the US and EU successfully argue that issues common to many regional deals, such as investment rules, should be part of the WTO's future approach.

In the past, the WTO has agreed a set agenda of issues to be negotiated in one round of trade talks. Countries focus on these and only these issues until the negotiations are complete. But the current round of trade talks, often referred to as the Doha Development Round but far from reflecting the priorities of developing countries, has made little progress. Just a few weeks ago, the US threatened to walk away from the WTO unless negotiations on the Doha Round stopped altogether and a new negotiating agenda is drawn up, including new issues, such as investment. This is a major blow to countries in the global south which have been arguing for new trade rules governing food security and agriculture throughout the Doha Round. A particular injustice has been the subsidies the EU and US provide to their farmers, while demanding that countries in the global south cannot subsidise their farmers in the same way.

WTO Director General, Roberto Azevedo, has urged the global south to be "flexible" and "pragmatic" in their response to this move by the US. The EU's Trade Commissioner, Cecilia Malmström, believes that "the Nairobi meeting can also do more to benefit the poorest and most vulnerable countries", demonstrating how countries in the global south could be split, with special and differential treatment reserved only for a smaller group of poorest and vulnerable countries. However, many countries from across the global south have spoken publicly and vociferously about why longstanding trade rules on agriculture must not be set aside.

The UK's delegation to the WTO is being led by new trade minister and Conservative heavyweight Lord Francis Maude. Lord Maude's involvement is a clear signal that the UK is taking the WTO ministerial seriously and has hopes of securing beneficial outcomes, possibly on TiSA, for the UK.

For the last week we have been asking our supporters to email Lord Maude, in his capacity as Trade Minister, about the WTO. Despite being a Trade Minister since May, he is yet to set up an email address for people to contact him directly and because he is not elected but sits in the House of Lords he has does not have any constituents to answer to. This lack of accountability and public scrutiny is symptomatic of a fundamental problem with all trade deals.

To date no MP has access to any of the negotiating texts for TTIP. The negotiations on TiSA are shrouded in secrecy with MPs and the public relying on Wikileaks for information. The UK Parliament has no opportunity to scrutinise and amend the negotiating texts of trade deals which are being negotiated in its name by the EU. Of course MPs can ask parliamentary questions, call debates and even hold select committee enquiries, such as the BIS inquiry on TTIP which criticised the government for making claims about the benefits of TTIP which could not be substantiated. But this is not good enough. As it stands, the UK Parliament will only get a say on TTIP, CETA or any other deal once the negotiations are complete and even then simply the opportunity to say yes or no to the complete deal with no chance of making amendments.

Geraint Davies MP for Swansea has been doggedly raising the lack of scrutiny of TTIP and other trade deals in Parliament and has secured a backbench debate on this today. With TTIP dominating MPs correspondence for many months, several MPs from across the political spectrum are expected to participate. It remains to be seen if the Government will act on their concerns.

It is clear that over the last decade trade has never been off the political agenda, it was simply being conducted away from public or parliamentary scrutiny. It is up to all of us — the tens of thousands of trade activists around the UK, and the millions more around the world — to pull these deals out into the open so we can expose their neoliberal content and challenge the principle that trade should put the interests of big business ahead of the needs of people and the planet.

Tags:
WTO
TPP

Blog

Zwarte Piet: blackface is the colonial hangover that's lasted too long


05 December 2018

I open the curtains to see fairy lights twinkling in my neighbour’s house. I open the kitchen door and see little crumbs on the table, traces of a mince pie eater. And then I open Facebook to see the annual arguments about blackface. Yep. It’s nearly Christmas.

Leading the world backwards: Governments are merely agreeing to disagree on trade and global warming

As world leaders finalised the Group of Twenty’s (G20) Agreements in Buenos Aires, Argentina, government and civil society climate representatives started arriving in Katowice, Poland for the 24th Conference of Parties (COP24) of the United Nations Framework Convention on Climate Change (UNFCCC).

It's time to get privatised medicines out of our public health system


03 December 2018

It’s good news for the NHS and patients. After years of big pharma having patent control over a medicine and hiking up its price extortionately, a drug that treats rheumatoid arthritis and Crohn's disease, adalimumab, is being replaced with much cheaper alternatives.